Bengt Hallberg

18PUBLICATIONS
56CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Solid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 23, 2024
Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Torben Ek, Raghda R Ibrahim, Hartmut Vogt

|Jun 10, 2024
Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth.

Wei-Yun Lai, Tzu-Po Chuang, Marcus Borenäs

|Feb 24, 2024
Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.

Mara Caputo, Emma Andersson, Ying Xia

|Jan 12, 2024
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN.

Jonatan L Gabre, Peter Merseburger, Arne Claeys

|Dec 28, 2023
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition.

Marcus Borenäs, Ganesh Umapathy, Dan E Lind

|Sep 09, 2023
IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway.

Jikui Guan, Marcus Borenäs, Junfeng Xiong

Pageof 3

Frequent Collaborators

12 joint publications

Ruth H Palmer

8 joint publications

Jikui Guan

8 joint publications

Jimmy Van den Eynden

5 joint publications

Dan Emil Lind